ArticleJournal of cachexia, sarcopenia and muscle2020

Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy.

Haiyan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.